Background: Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks synovial joints. About 1% of the world's population is afflicted by rheumatoid arthritis, women three times more often than men. Onset is most frequent between the ages of 40 and 50, but any age group can be affected.
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks synovial joints. The process produces an inflammatory response of the synovium (synovitis) secondary to hyperplasia of synovial cells, excess synovial fluid, and the development of pannus in the synovium (Majithia and Geraci 2007). A high percentage of patients with rheumatoid arthritis have substantial titres of antibody to peptides containing citrulline, and citrullinated peptides are found in rheumatoid synovium (Yelin et al., 1999) . The Anti citrullinated protein antibody (ACPA) tests, also known as the anti-cyclic citrullinated peptide (anti-CCP) antibody test, is an enzyme-linked immunosorbent assay that tests for the presence of antibodies that recognizes specific antigens containing citrulline (Schellekens et al., 1998). The specificity of anti-CCP is around 95-98% as regards undifferentiated forms of arthritis that do not develop into RA. IgM RF is often found in the same patients, but with much lower specificity for RA. One study using a CCP1 assay showed a sensitivity of 55% and a specificity of 97% for RA, when both anti-CCP and IgM RF were positive in the early stage of arthritis (Jansen et al., 2002). Several observations have indicated that anti-CCP positive early RA patients may develop a more erosive disease than those without anti-CCP. Other investigators have confirmed this, and suggested the superiority of anti-CCP over IgM RF in predicting an erosive disease course. The use of anti-CCP results in the decision whether a patient should be treated aggressively at an early stage or not is an important area for research (Kroot et al., 2000) .
Methods
This study was conducted on 80 Rhematiod patients were collected from Rheumatology outpatient clinics of Alhussein University Hospital, Sayed Galal University hospital and the National Research Center rheumatology clinic. The cases were diagnosed according to the 1987 classification criteria of the American College of Rheumatology (Arnett et al., 1988).
Inclusion criteria: 1-All cases were females.(there age ranged from 35-40).
2-All cases had disease duration of 3 to 5 years since the onset of diagnostic symptoms.
3-All cases were receiving steroid doses of 5 to 15 mg/day in combination with Non steroidal anti inflammatory drugs and either Methotrexate (doses ranged from 7.5 to 17.5mg/week) or Leflonamide.
Exclusion Criteria: Pregnancy, DM, ischemic heart disease, hypertension, chronic liver disease, chronic kidney disease, other autoimmune diseases or any other chronic diseases.
All participants accept to participate in this study.
Thorough history taking and clinical examination were done for each case, clinical findings of local examination were made using the Swelling tenderness limitation of movement warmth "STLW" score system. The DAS28 score was calculated for all patients (Aletaha et al., 2004).
DAS 28 Score:
Disease Activity Score (DAS) (Van Der Heijde et al., 1993) provides a composite measure of disease activity based on joint counts, ESR, and patient global assessment of general health rather than measuring response. This is not dependent on baseline parameters to show a difference and therefore provides a more absolute measure of disease severity, which can be followed over time. The DAS28 based on joint counts of 28 joints. (Prevoo et al., 1995).
The collected scores were calculated using the following formula: The following laboratory investigations were done:
Blood sampling:
Venous blood samples (random) were obtained from each subject in the study one mL was delivered into EDTA tube for CBC; 2mL were delivered into tube containing trisodium citrate for ESR. The rest was left to clot, centrifuged, and the separated serum was divided in 2 aliquots one used for routine biochemical laboratory investigations (liver, kidney, CRP and random blood glucose) while the second aliquot was stored freezed at -20 C until used for determination of Anti CCP and RF.
The following laboratory investigations were performed to all patients participating in this study : The principle of assay of anti-CCP antibody:
The anti-CCP antibody Kit is based on an ELISA method. The test utilizes microtitre plate wells coated with citrulinated synthetic peptides (antigen).
Diluted patients sample serum is applied to the wells and incubated. If specific antibodies are present, they will bind to the antigen in the wells. Unbound materials are washed away and any bound antibodies are detected by adding horse radish peroxidase (HRP) labeled anti-human IgG, followed by a second washing step and incubation with substrate. The presence of reacting antibodies will result in the development of colour, which is proportional to the quality of bound antibody, and this is determined photometrically.
Statistical analysis of data:
Statistics were done by computer using Epi -info. Software, version 6.04. A word processing, data base and statistics program (WHO, 2001) .The tests used were: X mean, SD standard deviation: to measure the central tendency of data and the distribution of data around their mean. Student's t test: for testing statistical significant difference between means of two samples. Median: is a measure of central tendency when extremes of values are found in data. X2 tests (Chi square test) to test statistical significant relation between different variable or grades (qualitative data) or percentages. Z test to test statistical significant difference between two percentages. F "analysis of variance" (or ANOVA test) to test statistical significant difference between more than 2 means i.e. differences between 3 or more groups at the same time. Pearson's correlation test (correlation coefficient r) to test a positive or negative linear relationship between two variables (one dependent and the other is independent variable).
RESULTS ANALYSIS:
Descriptive study.
The present study was carried out on 80 Rheumatoid arthritis female patients diagnosed according to the 1987 American College of Rheumatology criteria. All cases had disease duration of 3 to 5 years since the onset of diagnostic symptoms. Their age ranged from 35 to 40 years old), (Mean age was 38.01 ±3.4) The BMI (Body mass index) of the study group: (Mean 31.98 ±5.49), (Range: 21.7 to 53.9) and Waist to hip ratio: (Mean=1.15 ±0.2), (Range: 0.82 to 1.75). Extra-articular manifestations were present in 55 cases (68%) and subcutaneous nodules were present in 10 cases (12.5%).
-DAS 28 score: (Disease Activity score): It had a mean value of 5.35, range from 2.02 to 7.35 in the study group. -STLW score: (Swelling, Tenderness, And Limitation of movement, Warmth): It had a mean value of 29.5, range from 0 to 97 in the study group. -Deformities: were present in 23 cases (29%). -Radiographic progression: Modified Sharp score: It had a mean value of 24.8, range from zero to 128 in the study group. (Table 1) . Table 1 shows the studied group with respect to age, duration, weight, height, waist circumference, hip circumference, Body Mass Index, Waist /Hip ratio. The present study was conducted on 80 females of Rheumatoid arthritis. 45% were acute onset, 53.8% were gradual onset, 1.2% were insidious onset 11.3% were intermittent, 85% were progressive, and 3.7% were steady. Anti-CCP and RF results:
-The mean value of RF titre in the studied group was 82.59± 113.19 IU/ml, the range was <8 to 512 IU/ml and the median was 32 IU/ml. -The mean value of Anti-CCP titre in the studied group was 303.19 ±336.94 IU/ml, the range was 3.7 to 1213 IU/ml and the median was 194 IU/ml. Comparison study: By comparing the results of Anti-CCP and RF, this study demonstrated that there was a high significant difference between RF and Anti-CCP positive and negative results. Table  ( 3), Figure ( There was high statistical significant difference between positive or negative RF results in Anti-CCP readings.
There was high significant difference between positive or negative RF results in ACR class & VAS. There was high significant difference between positive or negative Anti-CCP in American College of Rheumatology disability class and in VAS (Visual analogue scale).
Correlation studies:
-A correlation study was performed between the results of RF and Anti-CCP showing significant positive correlation Fig (3) -A correlation between Anti-CCP and clinical , radiological and disability scorers showing the following:
1-There was significant positive correlation between Anti-CCP and ACR disability class. 2-There was significant positive correlation between Anti-CCP and RF results. 3 -There was positive but not significant correlation between Anti-CCP and STLW scores5 -The rest of items showed no statistical correlation. 
DISCUSSION
In the present study we aimed to investigate the vealue of Anti-CCP as a prognostic factor in Rheumatoid Arthritis and compare the results with Rheumatoid factor test.
Eighty female cases of Rheumatoid arthritis within the age group (Range 35 to 40 years old) were enrolled this study. All cases underwent detailed history taking, thorough clinical evaluation including functional impairment, radiological and laboratory assessment. (including Liver function tests, kidney function tests, random blood sugar, CBC, ESR, RF, and Anti-CCP).
Our results showed that there was a statistical significant higher RF titre in Anti-CCP positive patients compared with Anti-CCP negative patients (p <0.01) (mean value for RF titre was 111.27± 124.25 IU/ml with positive Anti-CCP and 16.88±27.09 IU/ml with negative Anti-CCP), and significant positive correlation between Anti-CCP titre and RF titres (r=0.81, p<0.05). also studied Anti-CCP and R.F tests titres as predictors of disease course and prognosis and used the same disease duration as our study (3 years) but he used about 3 times the number of patients (242). Their results showed there was a significant propensity for Anti-CCP antibody positive patients to be positive also for RF (p=0.001) with 78% of the RF positive and 40% of the RF negative patients were Anti-CCP antibody positive. They also concluded that Anti-CCP was better as a predictor of the disease course over 3 years than rheumatoid factor. Nehir et al. (2006) also found a significant correlation between the levels of Anti-CCP and RF (r=0.57, p<0.001).
Our results showed a statistically significant difference between positive and negative Anti-CCP and ACR disability classification (ACR class was higher with positive than with negative Anti-CCP) and a significant positive correlation between Anti-CCP titre and ACR disability classification. In their study, Farragher et al. (2010) made a similar study over a period of five years, patients who were anti-CCP positive had a mean change on their HAQ scores of 0.20 points (95% CI 0.09 to 0.31), which reflected a worsening of functional disability. Those who were negative for the antibodies had no worsening in HAQ score, with a mean change of 0.005 (95% CI −0.06 to 0.07). Although they used the HAQ itself as a measure for functional status/disability over a slightly longer disease duration than in our study (5 years We found that anti-CCP is a good prognostic marker for Rheumatoid arthritis patients especially with disability prediction, and gave more or less similar predictive values with Rheumatoid factor. The strongly positive correlation between the titres of both tests shows that they are likely to be similar with patients of different grades of severity. This agrees with the conclusion found by Yasser et al. (2010) . Who found that the currently available data suggested that anti-CCP is of good prognostic value besides RF. This is in contrast to Zendman et al. (2006) . Who found that Anti-CCP positivity has prognostic potential, but the absolute level of anti-CCP has not been demonstrated to be a useful measure of future severity of disease. Our results also disagree with Lindqvist et al. (2005) . who stated that combining RF with anti-CCP results appeared to help in prediction: RF+/anti-CCP+ patients had greater progression than RF+/anti-CCP-and RF-/CCPpatients at 5 years, while in our study, the subgroup analysis of RF and Anti-CCP positive and negative combinations did not yield additional data than that of Anti-CCP positive versus Anti-CCP negative alone.
Limitations:
The number of patients in the study group was small when compared to similar studies, and so did not allow better analysis of the findings. Also, the disease duration of the study group was short when compared to similar studies.
The main limitation of the Health Assessment Questionnaire used in our study was that it was not tailored for Egyptian lifestyle especially the low socioeconomic levels and the illiteracy of many of the patients in our study group prevented them from reading and filling the Questionnaire themselves (although it was translated into Arabic), which hampered the accuracy of the results. Radiographic and clinical assessment of the cases including DAS score calculation was not done periodically (once at baseline then once again every year as in most similar studies) to enable more accurate detection of progression and severity. In addition, specialized radiologists were not involved in the study for a better estimation of the radiographic score.
